Starting protocol: Begin with 1-2x weekly application Monitor for any purging or increased sensitivity Gradually increase frequency if tolerated Common effective range: 3-5x weekly Typical concentration: 1-3% GHK-Cu (as copper peptide) Expected timeline: Initial purge: 1-2 weeks (should be minimal on clear skin) Early improvements: 4-8 weeks Significant results: 3-6 months Maximum benefit: 6-12 months Quality and Sourcing (My Two Cents) Look, I run PeptidePrice.store specifically because quality varies wildly in the research peptide space
If you are unsure where you sit on this spectrum, a baseline lab panel is the right starting point
Short-term protocols are most common, but some patients use BPC-157 for maintenance under provider supervision
Conversely, scientists have transformed M0-type macrophages into M1-like ones using interferon-gamma (IFN-) and LPS, observing a notable increase in c-MET expression in M1 macrophages
Our commitment at Real Peptides to small-batch synthesis with exact amino-acid sequencing ensures you start with the highest possible purity, a foundational step in maximizing its lifespan
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising